| Product Code: ETC348241 | Publication Date: Aug 2022 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States (US) Structural Heart Devices Market was estimated at USD 446 Million in 2025 and is projected to reach USD 601 Million by 2032, growing at a CAGR of 4.4% from 2026 to 2032. This growth trajectory is fueled by a combination of an escalating prevalence of cardiovascular diseases and an aging population seeking innovative treatment options. As healthcare providers increasingly embrace minimally invasive techniques, patient demand for advanced structural heart solutions continues to rise, contributing to this robust market expansion.
This graph highlights how the United States (US) Structural Heart Devices Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 0.6% | Increased investment in healthcare technologies |
| 2022 | 7.2% | Rising prevalence of cardiovascular diseases |
| 2023 | 4.8% | strengthening underlying market demand |
| 2024 | 4.9% | Expansion of clinical research initiatives |
| 2025 | 5.4% | Technological advancements in medical solutions |
| 2026 | 5.0% | Increased patient awareness and education |
| 2027 | 5.5% | Aging population driving healthcare needs |
| 2028 | 5.6% | Enhanced reimbursement policies for treatments |
| 2029 | 5.4% | Emerging markets boosting industry growth |
| 2030 | 5.6% | Collaboration among healthcare stakeholders |
| 2031 | 5.5% | Focus on preventive healthcare measures |
| 2032 | 5.9% | Innovations in patient monitoring technologies |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
The US Structural Heart Devices Market is currently at the forefront of the medical device industry, highlighted by rapid advancements and a surge in demand. A significant rise in structural heart diseases, including valve defects and congenital conditions, is pushing healthcare providers to adopt cutting-edge treatments that enhance patient outcomes.
With a strong focus on technological innovations such as transcatheter interventions, this market is evolving rapidly. These devices not only provide effective solutions to complex heart conditions but also minimize recovery times, thereby positioning themselves as the preferred choice for both clinicians and patients.
Despite its promising trajectory, the US Structural Heart Devices Market encounters significant restraints that could hinder growth. Chief among these is the stringent regulatory landscape imposed by entities such as the FDA, which necessitates comprehensive clinical data and can result in prolonged approval times. Furthermore, the high costs associated with these innovative devices pose a challenge to broader adoption, especially among patients with inadequate insurance coverage. Limited reimbursement options further complicate the market dynamics, leading to hesitance among healthcare providers to offer these advanced treatment modalities.
Current trends in the US Structural Heart Devices Market reflect a shift toward minimally invasive procedures, which are favored for their efficiency and reduced recovery times. The rise in transcatheter heart valve technologies and left atrial appendage closure devices showcases this trend, aligning with patient preferences and clinical effectiveness. Additionally, advancements in imaging technologies, such as 3D echocardiography, are improving procedural outcomes and precision, ultimately driving further demand.
The market offers substantial investment opportunities, particularly in the realm of innovative technologies aimed at addressing structural heart conditions. Emerging procedures such as transcatheter aortic valve replacement (TAVR) and mitral valve repair are gaining traction as they cater to a growing patient demographic. Companies that focus on refining device efficacy and safety stand to benefit significantly, especially those that leverage new imaging techniques to enhance procedural success.
Government oversight in the US Structural Heart Devices Market is primarily channeled through the FDA, which ensures that medical devices meet safety and efficacy standards prior to market introduction. Legislative efforts like the Medical Device Regulation Act and the 21st Century Cures Act aim to expedite the approval process for innovative devices while prioritizing patient safety. Additionally, reimbursement policies from Medicare and other healthcare programs play a critical role in shaping the economic viability of these devices, influencing their adoption and market penetration.
Looking ahead, the US Structural Heart Devices Market is positioned for continued growth from 2026 to 2032. Factors such as an increase in the prevalence of structural heart diseases and persistent innovations in minimally invasive technologies will drive this market forward. The ongoing focus on enhancing patient outcomes and reducing healthcare costs will further bolster the demand for advanced structural heart solutions, promising a vibrant market landscape in the coming years.
Recent developments in the US Structural Heart Devices Market reflect a strong push towards innovative solutions that cater to evolving patient needs. Companies are actively enhancing their product offerings through research and development initiatives focused on creating next-generation devices. Additionally, strategic partnerships between technology firms and medical institutions are fostering advancements in imaging capabilities, which are integral to improving procedural accuracy and patient outcomes.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Structural Heart Devices Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Structural Heart Devices Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Structural Heart Devices Market - Industry Life Cycle |
3.4 United States (US) Structural Heart Devices Market - Porter's Five Forces |
3.5 United States (US) Structural Heart Devices Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 United States (US) Structural Heart Devices Market Revenues & Volume Share, By Procedure, 2022 & 2032F |
4 United States (US) Structural Heart Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of structural heart diseases in the US |
4.2.2 Technological advancements leading to the development of innovative structural heart devices |
4.2.3 Growing adoption of minimally invasive procedures for structural heart treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of structural heart devices |
4.3.2 High procedural costs associated with structural heart treatments |
4.3.3 Limited reimbursement policies for certain structural heart procedures |
5 United States (US) Structural Heart Devices Market Trends |
6 United States (US) Structural Heart Devices Market, By Types |
6.1 United States (US) Structural Heart Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Structural Heart Devices Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 United States (US) Structural Heart Devices Market Revenues & Volume, By Herat Valve Devices, 2022-2032F |
6.1.4 United States (US) Structural Heart Devices Market Revenues & Volume, By Surgical Heart Valves, 2022-2032F |
6.1.5 United States (US) Structural Heart Devices Market Revenues & Volume, By Transcatheter Heart Valves, 2022-2032F |
6.1.6 United States (US) Structural Heart Devices Market Revenues & Volume, By Occluders and Delivery Systems, 2022-2032F |
6.1.7 United States (US) Structural Heart Devices Market Revenues & Volume, By Annuloplasty Rings, 2022-2032F |
6.1.8 United States (US) Structural Heart Devices Market Revenues & Volume, By Other Devices, 2022-2032F |
6.2 United States (US) Structural Heart Devices Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Structural Heart Devices Market Revenues & Volume, By Replacement Procedures, 2022-2032F |
6.2.3 United States (US) Structural Heart Devices Market Revenues & Volume, By TAVR Procedures, 2022-2032F |
6.2.4 United States (US) Structural Heart Devices Market Revenues & Volume, By SAVR Procedures, 2022-2032F |
6.2.5 United States (US) Structural Heart Devices Market Revenues & Volume, By Repair Procedures, 2022-2032F |
6.2.6 United States (US) Structural Heart Devices Market Revenues & Volume, By Closure Procedures, 2022-2032F |
6.2.7 United States (US) Structural Heart Devices Market Revenues & Volume, By Annuloplasty, 2022-2032F |
6.2.8 United States (US) Structural Heart Devices Market Revenues & Volume, By TMVR Procedures, 2022-2032F |
6.2.9 United States (US) Structural Heart Devices Market Revenues & Volume, By TMVR Procedures, 2022-2032F |
7 United States (US) Structural Heart Devices Market Import-Export Trade Statistics |
7.1 United States (US) Structural Heart Devices Market Export to Major Countries |
7.2 United States (US) Structural Heart Devices Market Imports from Major Countries |
8 United States (US) Structural Heart Devices Market Key Performance Indicators |
8.1 Average procedure time for structural heart device implantation |
8.2 Number of hospitals offering structural heart procedures |
8.3 Patient outcomes and success rates of structural heart device treatments |
9 United States (US) Structural Heart Devices Market - Opportunity Assessment |
9.1 United States (US) Structural Heart Devices Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 United States (US) Structural Heart Devices Market Opportunity Assessment, By Procedure, 2022 & 2032F |
10 United States (US) Structural Heart Devices Market - Competitive Landscape |
10.1 United States (US) Structural Heart Devices Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Structural Heart Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here